DLX5
DLX5 is a gene that provides instructions for making a protein that is involved in the development of the bones and other tissues. This protein is a transcription factor, which means it attaches (binds) to specific regions of DNA and helps control the activity of certain genes.
The DLX5 protein is part of a group of proteins known as homeobox proteins. These proteins play a critical role in the formation of body structures during early embryonic development. The DLX5 protein is involved in the development of the bones of the skull, the inner ear, and the tissues that give rise to teeth.
Mutations in the DLX5 gene have been found to cause a variety of medical conditions, including Split-hand/foot malformation 1 and autosomal dominant deafness-63. These conditions are characterized by malformations of the limbs, hearing loss, and other abnormalities.
Function[edit]
The DLX5 gene provides instructions for making a protein that is involved in the development of the bones and other tissues. This protein is a transcription factor, which means it attaches (binds) to specific regions of DNA and helps control the activity of certain genes.
Clinical significance[edit]
Mutations in the DLX5 gene have been found to cause a variety of medical conditions, including Split-hand/foot malformation 1 and autosomal dominant deafness-63. These conditions are characterized by malformations of the limbs, hearing loss, and other abnormalities.
See also[edit]
References[edit]
External links[edit]
- DLX5 at the Genetics Home Reference
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
